Enhanced transfection rates of small-interfering RNA using dioleylglutamide-based magnetic lipoplexes

Nucleic Acid Therapeutics

Volumn 21, Issue 3, 2011, Pages 165-172

  Lee, Soondong ^a   Shim, Gayong ^b   Kim, Sunil ^c   Kim, Young Bong ^d   Kim, Chan Wha ^b   Byun, Youngro ^a,c   Oh, Yu Kyoung ^c  

^a Seoul National University   (South Korea)

^b Korea University   (South Korea)

^c Seoul National University   (South Korea)

^d Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; DOUBLE STRANDED RNA; GLUTAMINE DERIVATIVE; LIPOFECTAMINE; LIPOPLEX; N,N'' DIOLEYLGLUTAMIDE; SMALL INTERFERING RNA; SMALL INTERFERING RNA MCL1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GEL; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAGNETIC FIELD; MAGNETISM; MAGNETOFECTION; PRIORITY JOURNAL;

CELL LINE, TUMOR; CELL SURVIVAL; GLUTAMINE; HELA CELLS; HUMANS; LIPOPEPTIDES; LIPOSOMES; MAGNETITE NANOPARTICLES; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 80052146347     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2010.0274     Document Type: Article

References (26)

1. AICHBERGER, K.J., MAYERHOFER, M., GLEIXNER, K.V., KRAUTH, M.-T., GRUZE, A., PICKL, W.F., WACHECK, V., SELZER, E., MULLAUER, L., AGIS, H., SILLABER, C., and VALENT, P. (2007). Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412. Blood 109, 3031-3041. (Pubitemid 46482104)
2. AKINC, A., ZUMBUEHL, A., GOLDBERG, M., LESHCHINER, E.S., BUSINI, V., HOSSAIN, N., BACALLADO, S.A., NGUYEN, D.N., FULLER, J., ALVAREZ, R., BORODOVSKY, A., BORLAND, T., CONSTIEN, R., FOUGEROLLES, A.D., DORKIN, J.R., JAYAPRAKASH, K.N., JAYARAMAN, M., JOHN, M., KOTELIANSKY, V., MANOHARAN, M., NE-CHEV, L., QIN, J., RACIE, T., RAITCHEVA, D., RAJEEV, K.G., SAH, D.W.Y., SOUTSCHEK, J., TOUDJARSKA, I., VORNLOCHER, H.P., ZIMMERMANN, T.S., LANGER, R., and ANDERSON, D.G. (2008). A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat. Biotechnol. 26, 561-569. (Pubitemid 351668042)
3. BOE, S., LONGVA, A.S., and HOVIG, E. (2008). Evaluation of various polyethylenimine formulations for light-controlled gene silencing using small interfering RNA molecules. Oligo-nucleotides 18, 123-132. (Pubitemid 352019754)
4. BUERLI, T., PELLEGRINO, C., BAER, K., LARDI-STUDLER, B., CHUDOTVOROVA, I., FRITSCHY, J.-M., MEDINA, I., and FUHRER, C. (2007). Efficient transfection of DNA or shRNA vectors into neurons using magnetofection. Nat. Protoc. 2, 3090-3101.
5. CHOI, Y.J., KANG, S.J., KIM, Y.J., LIM, Y.B., and CHUNG, H.W. (2010). Comparative studies on the genotoxicity and cytotox-icity of polymeric gene carriers polyethylenimine (PEI) and polyamidoamine (PAMAM) dendrimer in Jurkat T-cells. Drug Chem. Toxicol. 33, 357-366.
6. ENSENAUER, R., HARTL, D., VOCKLEY, J., ROSCHER, A., and FUCHS, U. (2011). Efficient and gentle siRNA delivery by magnetofection. Biotech. Histochem. doi: 10.3109/1052029100 3675485.
7. HUNTER, A.C., and MOGHIMI, S.M. (2010). Cationic carriers of genetic material and cell death: a mitochondrial tale. Biochim. Biophys. Acta 1797, 1203-1209.
8. HUTH, S., LAUSIER, J., GERSTING, S.W., RUDOLPH, C., PLANK, C., WELSCH, U., and ROSENECKER, J. (2004). Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J. Gene Med. 6, 923-936. (Pubitemid 40228108)
9. LOVE, K.T., MAHON, K.P., LEVINS, C.G., WHITEHEAD, K.A., QUERBES, W., DORKIN, J.R., QIN, J., CANTLEY, W., QIN, L.L., RACIE, T., FRANK-KAMENETSKY, M., YIP, K.N., ALVAREZ, R., SAH, D.W., DE FOUGEROLLES, A., FITZGERALD, K., KOTELIABSKY, V., AKINC, A., LANGER, R., and ANDERSON, D.G. (2010). Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl. Acad. Sci. U. S. A. 107, 1864-1869.
10. LV, H., ZHANG, S., WANG, B., CUI, S., and YAN, J. (2006). Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release 114, 100-109. (Pubitemid 44128621)
11. MCBAIN, S.C., YIU, H.H., and DOBSON, J. (2008). Magnetic nanoparticles for gene and drug delivery. Int. J. Nanomed. 3, 169-180. (Pubitemid 352037850)
12. MCBAIN, S.C., YIU, H.H.P., EL HAJ, A., and DOBSON, J. (2007). Polyethylenimine functionalized iron oxide nano-particles as agents for DNA delivery and transfection. J. Mater. Chem. 17, 2561-2565. (Pubitemid 46906746)
13. MYKHAYLYK, O., ANTEQUERA, Y.S., VLASKOU, D., and PLANK, C. (2007). Generation of magnetic nonviral gene transfer agents and magnetofection in vitro. Nat. Protoc. 2, 2391-2411.
14. MYKHAYLYK, O., ZELPHATI, O., ROSENECKER, J., and PLANK, C. (2008). siRNA delivery by magnetofection. Curr. Opin. Mol. Ther. 10, 493-505.
15. NOH, S.M., HAN, S.E., SHIM, G., LEE, K.E., KIM, C.-W., HAN, S.S., CHOI, Y., KIM, Y.K., KIM, W.-K., and OH, Y.-K. (2011). Tocopheryl oligochitosan-based self assembling oligomer-somes for siRNA delivery. Biomaterials 32, 849-857.
16. OH, Y.K., and PARK, T.G. (2009). siRNA delivery systems for cancer treatment. Adv. Drug Deliv. Rev. 61, 850-862.
17. OZPOLAT, B., SOOD, A.K., and LOPEZ-BERESTEIN, G. (2010). Nanomedicine based approaches for the delivery of siRNA in cancer. J. Intern. Med. 267, 44-53.
18. PRIJIC, S., SCANCAR, J., ROMIH, R., CEMAZAR, M., BRE-GAR, V.B., ZNIDARSIC, A., and SERSA, G. (2010). Increased cellular uptake of biocompatible superparamagnetic iron oxide nanoparticles into malignant cells by an external magnetic field. J. Membr. Biol. 236, 167-179.
19. SAUER, A.M., DE BRUIN, K.G., RUTHARDT, N., Mykhaylyk, O., PLANK, C., and BRAUCHLE, C. (2009). Dynamics of magnetic lipoplexes studied by single particle tracking in living cells. J. Control. Release 137, 136-145.
20. SCHROEDER, A., LEVINS, C.G., CORTEZ, C., LANGER, R., and ANDERSON, D.G. (2010). Lipid-based nanotherapeutics for siRNA delivery. J. Intern. Med. 267, 9-21.
21. SHIM, G., HAN, S.E., YU, Y.H., LEE, S., LEE, H.Y., KIM, K., KWON, I.C., PARK, T.G., KIM, Y.B., CHOI, Y.S., KIM, C.W., and OH, Y.K. (2011). Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug. J. Control. Release doi: 10.1016/j.jconrel.2010.10.017.
22. SIMONIN, K., BROTIN, E., DUFORT, S., DUTOIT, S., GOUX, D., N'DIAYE, M., DENOYELLE, C., GAUDUCHON, P., and POULAIN, L. (2009). Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells. Mol. Cancer Ther. 8, 3162-3170.
23. SUH, M.S., SHIM, G., LEE, H.Y., HAN, S.-E., YU, Y.-H., CHOI, Y., KIM, K., KWON, I.C., WEON, K.Y., KIM, Y.B. and OH, Y.K. (2009). Anionic amino acid-derived cationic lipid for siRNA delivery. J. Control. Release 140, 268-276.
24. WHITEHEAD, K.A., LANGER, R., and ANDERSON, D.G. (2009). Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 8, 129-138.
25. XENARIOU, S., GRIESENBACH, U., FERRARI, S., DEAN, P., SCHEULE, R.K., CHENG, S.H., GEDDES, D.M., PLANK, C., and ALTON, E.W. (2006). Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo. Gene Ther. 13, 1545-1552. (Pubitemid 44567151)
26. YADAVA, P., ROURA, D., and HUGHES, J.A. (2007). Evaluation of two cationic delivery systems for siRNA. Oligonu-cleotides 17, 213-222.